Novel STAC3 Mutations in the First Non-Amerindian Patient with Native American Myopathy

Abstract

Native American myopathy (NAM) is an autosomal recessive congenital myopathy, up till now exclusively described in Lumbee Indians who harbor one single homozygous mutation (c.1046G>C, pW284S) in the STAC3 gene, encoding a protein important for proper excitation–contraction coupling in muscle. Here, we report the first non-Amerindian patient of Turkish ancestry, being compound heterozygous for the mutations c.862A>T (p.K288*) and c.432+4A>T (aberrant splicing with skipping of exon 4). Symptoms in NAM include congenital muscle weakness and contractures, progressive scoliosis, early ventilatory failure, a peculiar facial gestalt with mild ptosis and downturned corners of the mouth, short stature, and marked susceptibility to malignant hyperthermia. This case shows that NAM should also be considered in non-Indian patients with congenital myopathy, and suggests that STAC3 mutations should be taken into account as a potential cause of malignant hyperthermia.

Keywords

congenital myopathy - early-onset scoliosis - STAC3 gene - malignant hyperthermia

• References

• 1 Sewry CA, Jimenez-Mallebrera C, Muntoni F. Congenital myopathies. Curr Opin Neurol 2008; 21 (05) 569-575
• 2 Bailey AG, Bloch EC. Malignant hyperthermia in a three-month-old American Indian infant. Anesth Analg 1987; 66 (10) 1043-1045
• 3 Meluch AM, Sibert KS, Bloch EC. Malignant hyperthermia following isoflurane anesthesia in an American Lumbee Indian. N C Med J 1989; 50 (09) 485-487
• 4 Stamm DS, Powell CM, Stajich JM. , et al. Novel congenital myopathy locus identified in Native American Indians at 12q13.13-14.1. Neurology 2008; 71 (22) 1764-1769
• 5 Stamm DS, Aylsworth AS, Stajich JM. , et al. Native American myopathy: congenital myopathy with cleft palate, skeletal anomalies, and susceptibility to malignant hyperthermia. Am J Med Genet A 2008; 146A (14) 1832-1841
• 6 Horstick EJ, Linsley JW, Dowling JJ. , et al. Stac3 is a component of the excitation-contraction coupling machinery and mutated in Native American myopathy. Nat Commun 2013; 4: 1952
• 7 Auton A, Brooks LD, Durbin RM. , et al; 1000 Genomes Project Consortium. A global reference for human genetic variation. Nature 2015; 526 (7571): 68-74
• 8 Lek M, Karczewski KJ, Minikel EV. , et al; Exome Aggregation Consortium. Analysis of protein-coding genetic variation in 60,706 humans. Nature 2016; 536 (7616): 285-291
• 9 Stenson PD, Ball EV, Mort M. , et al. Human Gene Mutation Database (HGMD): 2003 update. Hum Mutat 2003; 21 (06) 577-581
• 10 Wang M, Marín A. Characterization and prediction of alternative splice sites. Gene 2006; 366 (02) 219-227
• 11 Jurkat-Rott K, McCarthy T, Lehmann-Horn F. Genetics and pathogenesis of malignant hyperthermia. Muscle Nerve 2000; 23 (01) 4-17
• 12 Cong X, Doering J, Mazala DAG, Chin ER, Grange RW, Jiang H. The SH3 and cysteine-rich domain 3 (Stac3) gene is important to growth, fiber composition, and calcium release from the sarcoplasmic reticulum in postnatal skeletal muscle. Skelet Muscle 2016; 6: 17
• 13 Nelson BR, Wu F, Liu Y. , et al. Skeletal muscle-specific T-tubule protein STAC3 mediates voltage-induced Ca2+ release and contractility. Proc Natl Acad Sci U S A 2013; 110 (29) 11881-11886
• 14 Polster A, Nelson BR, Olson EN, Beam KG. Stac3 has a direct role in skeletal muscle-type excitation-contraction coupling that is disrupted by a myopathy-causing mutation. Proc Natl Acad Sci U S A 2016; 113 (39) 10986-10991
• 15 Pollard KS, Hubisz MJ, Rosenbloom KR, Siepel A. Detection of nonneutral substitution rates on mammalian phylogenies. Genome Res 2010; 20 (01) 110-121